Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins

ABSTRACT Gammaretroviruses, such as murine leukemia viruses (MLVs), encode, in addition to the canonical Gag, Pol, and Env proteins that will form progeny virus particles, a protein called “glycogag” (glycosylated Gag). MLV glycogag contains the entire Gag sequence plus an 88-residue N-terminal exte...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yadvinder S. Ahi, Shu Zhang, Yashna Thappeta, Audrey Denman, Amin Feizpour, Suryaram Gummuluru, Bjoern Reinhard, Delphine Muriaux, Matthew J. Fivash, Alan Rein
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2016
Materias:	Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/85795b60f3f5406b8ecbecd387e23c47
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:85795b60f3f5406b8ecbecd387e23c47
record_format	dspace
spelling	oai:doaj.org-article:85795b60f3f5406b8ecbecd387e23c472021-11-15T15:50:16ZFunctional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins10.1128/mBio.01985-162150-7511https://doaj.org/article/85795b60f3f5406b8ecbecd387e23c472016-12-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01985-16https://doaj.org/toc/2150-7511ABSTRACT Gammaretroviruses, such as murine leukemia viruses (MLVs), encode, in addition to the canonical Gag, Pol, and Env proteins that will form progeny virus particles, a protein called “glycogag” (glycosylated Gag). MLV glycogag contains the entire Gag sequence plus an 88-residue N-terminal extension. It has recently been reported that glycogag, like the Nef protein of HIV-1, counteracts the antiviral effects of the cellular protein Serinc5. We have found, in agreement with prior work, that glycogag strongly enhances the infectivity of MLVs with some Env proteins but not those with others. In contrast, however, glycogag was detrimental to MLVs carrying Ebolavirus glycoprotein. Glycogag could be replaced, with respect to viral infectivity, by the unrelated S2 protein of equine infectious anemia virus. We devised an assay for viral entry in which virus particles deliver the Cre recombinase into cells, leading to the expression of a reporter. Data from this assay showed that both the positive and the negative effects of glycogag and S2 upon MLV infectivity are exerted at the level of virus entry. Moreover, transfection of the virus-producing cells with a Serinc5 expression plasmid reduced the infectivity and entry capability of MLV carrying xenotropic MLV Env, particularly in the absence of glycogag. Conversely, Serinc5 expression abrogated the negative effects of glycogag upon the infectivity and entry capability of MLV carrying Ebolavirus glycoprotein. As Serinc5 may influence cellular phospholipid metabolism, it seems possible that all of these effects on virus entry derive from changes in the lipid composition of viral membranes. IMPORTANCE Many murine leukemia viruses (MLVs) encode a protein called “glycogag.” The function of glycogag is not fully understood, but it can assist HIV-1 replication in the absence of the HIV-1 protein Nef under some circumstances. In turn, Nef counteracts the cellular protein Serinc5. Glycogag enhances the infectivity of MLVs with some but not all MLV Env proteins (which mediate viral entry into the host cell upon binding to cell surface receptors). We now report that glycogag acts by enhancing viral entry and that, like Nef, glycogag antagonizes Serinc5. Surprisingly, the effects of glycogag and Serinc5 upon the entry and infectivity of MLV particles carrying an Ebolavirus glycoprotein are the opposite of those observed with the MLV Env proteins. The unrelated S2 protein of equine infectious anemia virus (EIAV) is functionally analogous to glycogag in our experiments. Thus, three retroviruses (HIV-1, MLV, and EIAV) have independently evolved accessory proteins that counteract Serinc5.Yadvinder S. AhiShu ZhangYashna ThappetaAudrey DenmanAmin FeizpourSuryaram GummuluruBjoern ReinhardDelphine MuriauxMatthew J. FivashAlan ReinAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 7, Iss 6 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	Microbiology QR1-502
spellingShingle	Microbiology QR1-502 Yadvinder S. Ahi Shu Zhang Yashna Thappeta Audrey Denman Amin Feizpour Suryaram Gummuluru Bjoern Reinhard Delphine Muriaux Matthew J. Fivash Alan Rein Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins
description	ABSTRACT Gammaretroviruses, such as murine leukemia viruses (MLVs), encode, in addition to the canonical Gag, Pol, and Env proteins that will form progeny virus particles, a protein called “glycogag” (glycosylated Gag). MLV glycogag contains the entire Gag sequence plus an 88-residue N-terminal extension. It has recently been reported that glycogag, like the Nef protein of HIV-1, counteracts the antiviral effects of the cellular protein Serinc5. We have found, in agreement with prior work, that glycogag strongly enhances the infectivity of MLVs with some Env proteins but not those with others. In contrast, however, glycogag was detrimental to MLVs carrying Ebolavirus glycoprotein. Glycogag could be replaced, with respect to viral infectivity, by the unrelated S2 protein of equine infectious anemia virus. We devised an assay for viral entry in which virus particles deliver the Cre recombinase into cells, leading to the expression of a reporter. Data from this assay showed that both the positive and the negative effects of glycogag and S2 upon MLV infectivity are exerted at the level of virus entry. Moreover, transfection of the virus-producing cells with a Serinc5 expression plasmid reduced the infectivity and entry capability of MLV carrying xenotropic MLV Env, particularly in the absence of glycogag. Conversely, Serinc5 expression abrogated the negative effects of glycogag upon the infectivity and entry capability of MLV carrying Ebolavirus glycoprotein. As Serinc5 may influence cellular phospholipid metabolism, it seems possible that all of these effects on virus entry derive from changes in the lipid composition of viral membranes. IMPORTANCE Many murine leukemia viruses (MLVs) encode a protein called “glycogag.” The function of glycogag is not fully understood, but it can assist HIV-1 replication in the absence of the HIV-1 protein Nef under some circumstances. In turn, Nef counteracts the cellular protein Serinc5. Glycogag enhances the infectivity of MLVs with some but not all MLV Env proteins (which mediate viral entry into the host cell upon binding to cell surface receptors). We now report that glycogag acts by enhancing viral entry and that, like Nef, glycogag antagonizes Serinc5. Surprisingly, the effects of glycogag and Serinc5 upon the entry and infectivity of MLV particles carrying an Ebolavirus glycoprotein are the opposite of those observed with the MLV Env proteins. The unrelated S2 protein of equine infectious anemia virus (EIAV) is functionally analogous to glycogag in our experiments. Thus, three retroviruses (HIV-1, MLV, and EIAV) have independently evolved accessory proteins that counteract Serinc5.
format	article
author	Yadvinder S. Ahi Shu Zhang Yashna Thappeta Audrey Denman Amin Feizpour Suryaram Gummuluru Bjoern Reinhard Delphine Muriaux Matthew J. Fivash Alan Rein
author_facet	Yadvinder S. Ahi Shu Zhang Yashna Thappeta Audrey Denman Amin Feizpour Suryaram Gummuluru Bjoern Reinhard Delphine Muriaux Matthew J. Fivash Alan Rein
author_sort	Yadvinder S. Ahi
title	Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins
title_short	Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins
title_full	Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins
title_fullStr	Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins
title_full_unstemmed	Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins
title_sort	functional interplay between murine leukemia virus glycogag, serinc5, and surface glycoprotein governs virus entry, with opposite effects on gammaretroviral and ebolavirus glycoproteins
publisher	American Society for Microbiology
publishDate	2016
url	https://doaj.org/article/85795b60f3f5406b8ecbecd387e23c47
work_keys_str_mv	AT yadvindersahi functionalinterplaybetweenmurineleukemiavirusglycogagserinc5andsurfaceglycoproteingovernsvirusentrywithoppositeeffectsongammaretroviralandebolavirusglycoproteins AT shuzhang functionalinterplaybetweenmurineleukemiavirusglycogagserinc5andsurfaceglycoproteingovernsvirusentrywithoppositeeffectsongammaretroviralandebolavirusglycoproteins AT yashnathappeta functionalinterplaybetweenmurineleukemiavirusglycogagserinc5andsurfaceglycoproteingovernsvirusentrywithoppositeeffectsongammaretroviralandebolavirusglycoproteins AT audreydenman functionalinterplaybetweenmurineleukemiavirusglycogagserinc5andsurfaceglycoproteingovernsvirusentrywithoppositeeffectsongammaretroviralandebolavirusglycoproteins AT aminfeizpour functionalinterplaybetweenmurineleukemiavirusglycogagserinc5andsurfaceglycoproteingovernsvirusentrywithoppositeeffectsongammaretroviralandebolavirusglycoproteins AT suryaramgummuluru functionalinterplaybetweenmurineleukemiavirusglycogagserinc5andsurfaceglycoproteingovernsvirusentrywithoppositeeffectsongammaretroviralandebolavirusglycoproteins AT bjoernreinhard functionalinterplaybetweenmurineleukemiavirusglycogagserinc5andsurfaceglycoproteingovernsvirusentrywithoppositeeffectsongammaretroviralandebolavirusglycoproteins AT delphinemuriaux functionalinterplaybetweenmurineleukemiavirusglycogagserinc5andsurfaceglycoproteingovernsvirusentrywithoppositeeffectsongammaretroviralandebolavirusglycoproteins AT matthewjfivash functionalinterplaybetweenmurineleukemiavirusglycogagserinc5andsurfaceglycoproteingovernsvirusentrywithoppositeeffectsongammaretroviralandebolavirusglycoproteins AT alanrein functionalinterplaybetweenmurineleukemiavirusglycogagserinc5andsurfaceglycoproteingovernsvirusentrywithoppositeeffectsongammaretroviralandebolavirusglycoproteins
_version_	1718427469154877440

Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins

Ejemplares similares